CD19/CD20 Double Knockout Raji Cell Line
82623
CategoryCells Cell Lines
Product group Cell Culture
Overview
- SupplierBPS Bioscience
- Product NameCD19/CD20 Double Knockout Raji Cell Line
- Delivery Days Customer7
- CertificationResearch Use Only
- Gene ID931
- Target nameMS4A1
- Target descriptionmembrane spanning 4-domains A1
- Target synonymsB1, Bp35, CD20, CVID5, FMC7, LEU-16, S7, B-lymphocyte antigen CD20, B-lymphocyte cell-surface antigen B1, CD20 antigen, CD20 receptor, leukocyte surface antigen Leu-16, membrane-spanning 4-domains, subfamily A, member 1
- Protein IDP11836
- Protein NameB-lymphocyte antigen CD20
- Scientific DescriptionCD19/CD20 Double Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) and CD20 (B-lymphocyte antigen CD20, or MS4A1) have been genetically removed from Raji cells using CRISPR/Cas9 genome editing. This cell line has been validated by genome sequencing and flow cytometry.
- UNSPSC41116106
- SpeciesHuman